Mori, T., Murasaki, K., & Yokoyama, Y. (2023). Pharmacokinetics of Single and Multiple Oral Administration of a Self‐emulsifying Formulation of Highly Purified Eicosapentaenoic Acid Ethyl Ester (MND‐2119) Compared With the Nonself‐emulsifying Formulation in Healthy Male Subjects. Clinical pharmacology in drug development, 12(1), 107-115. https://doi.org/10.1002/cpdd.1177
Chicago Style (17th ed.) CitationMori, Takuya, Kagari Murasaki, and Yuichi Yokoyama. "Pharmacokinetics of Single and Multiple Oral Administration of a Self‐emulsifying Formulation of Highly Purified Eicosapentaenoic Acid Ethyl Ester (MND‐2119) Compared With the Nonself‐emulsifying Formulation in Healthy Male Subjects." Clinical Pharmacology in Drug Development 12, no. 1 (2023): 107-115. https://doi.org/10.1002/cpdd.1177.
MLA (9th ed.) CitationMori, Takuya, et al. "Pharmacokinetics of Single and Multiple Oral Administration of a Self‐emulsifying Formulation of Highly Purified Eicosapentaenoic Acid Ethyl Ester (MND‐2119) Compared With the Nonself‐emulsifying Formulation in Healthy Male Subjects." Clinical Pharmacology in Drug Development, vol. 12, no. 1, 2023, pp. 107-115, https://doi.org/10.1002/cpdd.1177.